Get the Stockscreener App
0.657
2.23%
-0.015
After Hours:
.66
0.003
+0.46%
Karyopharm Therapeutics Inc Stock (KPTI) Latest News
Karyopharm awards stock options to top executives - MSN
A History of Outperforming Analyst Forecasts and Beating the Odds: Karyopharm Therapeutics Inc (KPTI) - SETE News
Karyopharm Therapeutics Inc: Rising -65.54% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Karyopharm Therapeutics Inc [KPTI] President and CEO makes an insider sale of 4,055 shares worth $3175.0. - Knox Daily
Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Karyopharm Therapeutics Inc (KPTI) stock analysis: A simple moving average approach - US Post News
Karyopharm's Strategic Move: 28,000 RSUs Granted to Secure Top Industry Talent - StockTitan
Daily Market Movement: Karyopharm Therapeutics Inc (KPTI) Sees a -6.32 Decrease, Closing at 0.62 - The Dwinnex
Karyopharm awards stock options to top executives By Investing.com - Investing.com Nigeria
Karyopharm Announces Executive Retention Equity Awards - TipRanks
Karyopharm increases authorized shares, approves reverse split By Investing.com - Investing.com South Africa
Karyopharm increases authorized shares, approves reverse split - Investing.com
Karyopharm Therapeutics' SWOT analysis: biotech stock faces pivotal year By Investing.com - Investing.com Australia
Karyopharm Therapeutics' SWOT analysis: biotech stock faces pivotal year - MSN
Karyopharm Therapeutics (NASDAQ:KPTI) Shares Cross Below 200 Day Moving Average – What’s Next? - Defense World
Barclays PLC Has $79,000 Holdings in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
Barclays PLC Has $79,000 Stock Holdings in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat
Karyopharm Therapeutics (NASDAQ:KPTI) Shares Cross Below 200-Day Moving AverageHere's Why - MarketBeat
What is HC Wainwright’s Estimate for KPTI FY2024 Earnings? - Defense World
Karyopharm Therapeutics’ (KPTI) “Buy” Rating Reiterated at HC Wainwright - Defense World
What is HC Wainwright's Forecast for KPTI FY2024 Earnings? - MarketBeat
HC Wainwright Reiterates Buy Rating for Karyopharm Therapeutics (NASDAQ:KPTI) - MarketBeat
Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year - Investing.com India
Karyopharm Therapeutics’ SWOT analysis: oncology firm’s stock faces pivotal year - Investing.com Nigeria
Jane Street Group LLC Sells 1,345,226 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat
Jane Street Group LLC Has $170,000 Stake in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
KPTIKaryopharm Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
Karyopharm announces preliminary 2024 revenue - MSN
Karyopharm Reports $145M Revenue for 2024, Advances Phase 3 Myelofibrosis Trial - StockTitan
Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives - PR Newswire
Why Karyopharm Therapeutics (KPTI) Is Among the Best Penny Stocks to Invest In According to Media? - MSN
Geode Capital Management LLC Has $1.13 Million Stake in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - Defense World
Barclays PLC Sells 777,507 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat
Karyopharm CEO sells common stock for $3,175 By Investing.com - Investing.com Canada
12 Best Penny Stocks to Invest in According to the Media - Insider Monkey
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Position Reduced by State Street Corp - Defense World
Karyopharm appoints new CFO effective January 3 By Investing.com - Investing.com Australia
Karyopharm appoints new CFO effective January 3 - Investing.com India
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Karyopharm Appoints Lori Macomber as Chief Financial Officer - citybiz
Karyopharm Welcomes New Chief Financial Officer - Contract Pharma
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer, Effective January 3, 2025 - Marketscreener.com
Karyopharm appoints new CFO to bolster financial strategy - Investing.com
Karyopharm Therapeutics names Lori Macomber as CFO - MSN
Karyopharm Appoints Lori Macomber as New CFO - TipRanks
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer - Citizentribune
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):